Dr. Rothman was a recipient of the 2013 Nobel Prize in Physiology or Medicine and the 2002 Albert Lasker Basic Medical Research. Award.He is the Sterling Professor of Cell Biology at Yale University School of Medicine. Dr. Rothman is the Chair of Arsenal Capital Partners’ Healthcare Advisory Board. Previously he was the Chief Scientist of GE Healthcare and has served in senior advisory roles at Genentech, Merck, GSK, Johnson & Johnson, and Eli Lilly. He was previously a professor at Stanford, Princeton, and Columbia Universities and at Memorial Sloan-Kettering Cancer Center, where he served as Vice-Chairman of the Sloan-Kettering Institute.

Dr Baldoni held various positions at GSK including SVP, Preclinical Development; VP, Product Development; Director, Product Development; and Ass. Director, Biopharmaceutical Formulation Development, among others. He has worked in the pharmaceutical industry for 42 years. His experience spans new chemical entity design, development & commercialization, and biopharmaceutical development. Dr Baldoni led the innovative drug discovery unit dedicated to exploring and applying in-silico methodology to drug discovery & development at GSK.